The 2025 César Milstein Lecture titled ‘Mechanisms driving the rapid evolution of genomes’ will be given by David Pellman at 10am (BST) on Thursday 24th April.
2025 César Milstein Lecture to be delivered by David Pellman
Benjamin Ryskeldi-Falcon awarded The Colworth Medal from the Biochemical Society
Benjamin Ryskeldi-Falcon, Group Leader in the LMB’s Neurobiology Division, has been recognised for his research into the molecular basis of neurodegenerative diseases.
LMB highlights the scale of molecular biology at the Cambridge Festival
LMB scientists showcased their work at the Cambridge Festival with a hands-on activity about the molecular mechanisms of behaviour and science and art collaboration about body clocks.
LMB spinout TRIMTECH Therapeutics will develop targeted protein degraders to treat neurodegenerative conditions
Leo James co-founds new UK biotech company together with Will McEwan (UK DRI at Cambridge) leveraging the unique properties of TRIM21, discovered at the LMB.
Sortera Bio spins out of the LMB to pioneer new frontiers in biologics discovery
New UK-based biotechnology company launched to realise therapeutic potential of Deep Screening technology developed by Ben Porebski and Philipp Holliger at the LMB.
Shankar Balasubramanian to deliver 2025 Francis Crick Lecture
The 2025 Francis Crick Lecture titled ‘The DNA Quadruplex Helix’ will be given by Shankar Balasubramanian at 11am on Wednesday 19th February.